These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8858355)

  • 1. Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?
    Williams RG; Chang S; Comaratta MR; Simoni G
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234(8):496-503. PubMed ID: 8858355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial.
    Asaria RH; Kon CH; Bunce C; Charteris DG; Wong D; Khaw PT; Aylward GW
    Ophthalmology; 2001 Jul; 108(7):1179-83. PubMed ID: 11425671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
    Scott IU; Flynn HW; Murray TG; Feuer WJ;
    Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-Release Dexamethasone in Proliferative Vitreoretinopathy: A Prospective, Randomized Controlled Clinical Trial.
    Banerjee PJ; Quartilho A; Bunce C; Xing W; Zvobgo TM; Harris N; Charteris DG
    Ophthalmology; 2017 Jun; 124(6):757-767. PubMed ID: 28237428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined 5-fluorouracil, low-molecular-weight heparin, and silicone oil in the management of complicated retinal detachment with proliferative vitreoretinopathy grade C.
    Garcia RA; Sanchez JG; Arevalo JF
    Ophthalmic Surg Lasers Imaging; 2007; 38(4):276-82. PubMed ID: 17674917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11.
    Abrams GW; Azen SP; McCuen BW; Flynn HW; Lai MY; Ryan SJ
    Arch Ophthalmol; 1997 Mar; 115(3):335-44. PubMed ID: 9076205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.
    Mancino R; Aiello F; Ciuffoletti E; Di Carlo E; Cerulli A; Nucci C
    BMC Ophthalmol; 2015 Dec; 15():173. PubMed ID: 26645589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial.
    Schaub F; Schiller P; Hoerster R; Kraus D; Holz FG; Guthoff R; Agostini H; Spitzer MS; Wiedemann P; Lommatzsch A; Boden KT; Dimopoulos S; Bemme S; Tamm S; Maier M; Roider J; Enders P; Altay L; Fauser S; Kirchhof B;
    Ophthalmology; 2022 Oct; 129(10):1129-1141. PubMed ID: 35680097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy.
    Lai FH; Lo EC; Chan VC; Brelen M; Lo WL; Young AL
    Int Ophthalmol; 2016 Apr; 36(2):217-24. PubMed ID: 26260357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, anatomical, and visual outcomes of injured eyes with proliferative vitreoretinopathy: eye injury vitrectomy study.
    Feng K; Hu Y; Wang C; Shen L; Pang X; Jiang Y; Nie H; Wang Z; Ma Z
    Retina; 2013 Sep; 33(8):1512-8. PubMed ID: 23538583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitrectomy without scleral buckling for proliferative vitreoretinopathy.
    Oyagi T; Emi K
    Retina; 2004 Apr; 24(2):215-8. PubMed ID: 15097880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored vitrectomy and laser photocoagulation without scleral buckling for all primary rhegmatogenous retinal detachments.
    Johansson K; Malmsjö M; Ghosh F
    Br J Ophthalmol; 2006 Oct; 90(10):1286-91. PubMed ID: 16837538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent retinal detachment more than 1 year after reattachment.
    Foster RE; Meyers SM
    Ophthalmology; 2002 Oct; 109(10):1821-7. PubMed ID: 12359601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional outcome and prognostic factors in 304 eyes managed by retinectomy.
    Grigoropoulos VG; Benson S; Bunce C; Charteris DG
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):641-9. PubMed ID: 17119994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of segmental buckling surgery in treatment of stages B and C proliferative vitreoretinopathy detachment. A long-term follow-up].
    Kreissig I; Simader E; Rose D
    Klin Monbl Augenheilkd; 1994 Dec; 205(6):336-43. PubMed ID: 7869683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10.
    Diddie KR; Azen SP; Freeman HM; Boone DC; Aaberg TM; Lewis H; Radtke ND; Ryan SJ
    Ophthalmology; 1996 Jul; 103(7):1092-9. PubMed ID: 8684799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective comparison of 25-gauge vitrectomy for repair of proliferative vitreoretinopathy with or without anterior proliferation.
    Sato T; Emi K; Bando H; Ikeda T
    Graefes Arch Clin Exp Ophthalmol; 2014 Dec; 252(12):1895-902. PubMed ID: 25377435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitrectomy in proliferative vitreoretinopathy. Anatomical and functional results in 501 patients].
    Körner F; Böhnke M
    Klin Monbl Augenheilkd; 1995 Apr; 206(4):239-45. PubMed ID: 7791283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitrectomy and scleral buckling methods for proliferative vitreoretinopathy.
    Hanneken AM; Michels RG
    Ophthalmology; 1988 Jul; 95(7):865-9. PubMed ID: 3174035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of perfluoro-octane in the management of giant retinal tears without proliferative vitreoretinopathy.
    Ie D; Glaser BM; Sjaarda RN; Thompson JT; Steinberg LE; Gordon LW
    Retina; 1994; 14(4):323-8. PubMed ID: 7817025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.